Life ScienceCompany
Karuna Therapeutics Ownership
Who owns Karuna Therapeutics?
Karuna Therapeutics is owned by Bristol-Myers Squibb. It was acquired on December 22, 2023.
Karuna Therapeutics Business Overview
Where is Karuna Therapeutics headquartered?
Karuna Therapeutics is headquartered in Boston, Massachusetts.
What is Karuna Therapeutics’ revenue?
Karuna Therapeutics disclosed revenue of 11M USD for 2022 and 37M USD for 2021.
What sector is Karuna Therapeutics in?
Karuna Therapeutics is a life science company.
Life Science M&A Summary in 2023
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.
Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.